Natus Medical Inc. buy melinda
Start price
30.11.18
/
50%
€32.18
Target price
17.12.18
€33.37
Performance (%)
-10.87%
End price
17.12.18
€28.68
Summary
This prediction ended on 17.12.18 with a price of €28.68. The price of Natus Medical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.87%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Natus Medical Inc. | - | - | - | - |
| iShares Core DAX® | 1.395% | -0.696% | 15.472% | 15.907% |
| iShares Nasdaq 100 | 2.287% | 7.501% | 34.748% | 53.474% |
| iShares Nikkei 225® | 1.617% | 2.769% | 11.442% | 8.194% |
| iShares S&P 500 | 0.659% | 4.280% | 26.778% | 45.322% |
Comments by melinda for this prediction
In the thread Natus Medical Inc. diskutieren
SecteurEquipement et technologie médicale avancés Agenda 13/12 | 17:00 Assemblée générale
Natus Medical, Inc. engages in the provision of newborn care, neurology, and hearing and balance assessment healthcare products and services.
Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Pleasanton, CA.
Nombre d'employés : 1 726 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Natus Medical Inc.
Natus Medical Inc.
Start price
Target price
Perf. (%)
€14.80
29.08.20
29.08.20
€17.00
04.11.21
04.11.21
54.05%
05.11.21
05.11.21
